Results 41 to 50 of about 316,722 (312)

The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017

open access: yesEFSA Journal, 2019
The data on antimicrobial resistance in zoonotic and indicator bacteria in 2017, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC.
European Food Safety Authority   +1 more
doaj   +1 more source

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10‐Year, Single‐Institution Experience Encompassing the COVID‐19 Pandemic

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa   +8 more
wiley   +1 more source

Temporal multimorbidity patterns and cluster identification: a longitudinal analysis of administrative data

open access: yesBMC Medicine
Background Multimorbidity is analytically and clinically complex, involving multiple interactions between diseases each with unique implications for health.
Jennifer K. Ferris   +6 more
doaj   +1 more source

The European Union summary report on trends and sources of zoonoses, zoonotic agents and food‐borne outbreaks in 2015

open access: yesEFSA Journal, 2016
This report of EFSA and the European Centre for Disease Prevention and Control presents the results of the zoonoses monitoring activities carried out in 2015 in 32 European countries (28 Member States (MS) and four non‐MS).
European Food Safety Authority   +1 more
doaj   +1 more source

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro   +11 more
wiley   +1 more source

Authority control. Teorie, applicazioni e prospettive di sviluppo [PDF]

open access: yes, 2004
The authority control, though being a process which integrates the catalogue architecture – and which assures the indexes quality (author, title, descriptor) and supports the relational and syndetic structure of the catalogue, endorsing capabilities of ...
Bozzarelli, Oriana
core  

Deep Sequencing of FLT3‐ITD Enables Response Evaluation and Post‐Treatment Monitoring in Childhood AML: An Exploratory Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background An internal tandem duplication in the gene encoding Fms‐like tyrosine kinase 3 (FLT3‐ITD) is associated with high relapse risk and poor prognosis in acute myeloid leukemia (AML) and plays a crucial role in treatment decisions. Measurable residual disease (MRD) analysis of FLT3‐ITD during and after treatment has shown prognostic ...
Sofie Johansson Alm   +11 more
wiley   +1 more source

Automating Authority Control Procedures

open access: yes, 2020
This paper is a part of the presentation, "Automating the Authority Control Process," for the Innovative Users Group Conference in 2020. The presentation introduces ideas on how to handle authority control using a variety of tools, both paid and free ...
Wolf, Stacey
core  

AUTHORIS : a tool for authority control in the Semantic Web [PDF]

open access: yes, 2013
Purpose – The purpose of this paper is to propose a tool that generates authority files to be integrated with linked data by means of learning rules. AUTHORIS is software developed to enhance authority control and information exchange among bibliographic
Leiva-Mederos, Amed   +3 more
core  

Claudin‐6 Protein Expression in Atypical Teratoid/Rhabdoid Tumors Is Strongly Enriched in the Molecular Subgroup AT/RT‐TYR

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy